Trial | NCT01710761  Report issue

Official Title

Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    16
Acute supplementation of Neo40(TM), a nitrate lozenge, will improve cycling performance
Study Started
Oct 31
2012
Primary Completion
Feb 28
2013
Anticipated
Study Completion
May 31
2013
Anticipated
Last Update
Jan 23
2013
Estimate

Dietary Supplement Placebo

Same form factor and flavor as test lozenge but contains no active ingredients

Dietary Supplement Nitrate supplement with caffeine

Lozenge consisting of beetroot and 75 mg caffeine

Nitrate supplement with caffeine Active Comparator

Placebo Placebo Comparator

Criteria 

Inclusion Criteria:

Regular commuter cyclist or spin class participant
Male (VO2max < 50) or Female (VO2max < 45)
Healthy
Blood pressure below 140/90
Non-smoker

Exclusion Criteria:

Does not cycle 2-3 times/week
Regular consumption of performance-enhancing substances
Type I or Type II diabetes
Renal, hepatic or cardiac disease
Current infectious disease
No Results Posted